Skip to main content
. 2023 Mar 16;14(Suppl 1):2506. doi: 10.4081/jphia.2023.2506

Figure 3.

Figure 3.

The IL-1ß levels on the pretest increased in rat serum compared with the naïve group. The cytokine was measured in the serum of EBE treated rats at three doses (6, 12, and 24 mg/200 g BW) together with negative (CMC) and positive (meloxicam) groups. The levels of IL-1ß were decreased after treatment as compared with the negative control group (P<0.01). Data are present as Mean±SD base on n=5 for all groups. *P<0.05; **P<0.01.